243 filings
Page 8 of 13
8-K
834a8r1672bma26q
8 May 17
CytoSorbents Announces Positive REFRESH I Trial Results
12:00am
8-K
k91ok
24 Apr 17
Targeting significant annual sales growth, near-term operating profitability, a U.S. pivotal trial, and greater investor awareness and ownership
12:00am
8-K
9vechsh4nvuh0s15hhe
11 Apr 17
Other Events
12:00am
8-K
o7xohchs pwamr8
5 Apr 17
Other Events
12:00am
8-K
yej6v1derkbf lb9
3 Apr 17
CytoSorbents Announces Proposed Offering of Common Stock
12:00am
8-K
np76xxg fo909ovnb
28 Mar 17
CytoSorbents Strengthens Intellectual Property Portfolio with New Patents Issued in the U.S., China, Japan, Russia, and Australia
12:00am
8-K
e3ckmo 4em
9 Mar 17
2016 Earnings and Operating Results Conference Call
12:00am
8-K
0rtnppun7nc0mmp0h
28 Feb 17
Departure of Directors or Certain Officers
12:00am
8-K
qymfcuze3tulfjg gbo
10 Jan 17
Other Events
12:00am
8-K
crhmal yyj
10 Jan 17
CytoSorbents Pre-announces Q4 2016 and Full-Year 2016 Results
12:00am
8-K
c0iql
7 Nov 16
CytoSorb® Q3 2016 Sales Reach Record $2.14M, Doubling From a Year Ago
12:00am
8-K
nu19dcohrvyxq2l7
11 Oct 16
CytoSorbents Announces Positive Top-line Safety Data from REFRESH I Cardiac Surgery Trial
12:00am
8-K
cqpndez
11 Aug 16
CytoSorbents Achieves Fourth Consecutive Quarter of Record CytoSorb® Sales
12:00am
8-K
5rrk4c8 eo
1 Jul 16
CytoSorbents Closes $10 Million Debt Financing with Bridge Bank
12:00am
8-K
58qekz 1i
10 Jun 16
Departure of Directors or Certain Officers
12:00am
8-K
rs74td i7f7tlsc
8 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
gesn0ceqy
12 May 16
CytoSorbents Continues Strong Growth in Q1 2016
12:00am
8-K
rykewbwu4
5 Apr 16
Other Events
12:00am
8-K
gj4u sgee
16 Mar 16
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
8-K
cynxd79pk
15 Mar 16
2015 Earnings and Operating Results Conference Call
12:00am